Nightstar Expands Pipeline with Novel Gene Therapy for the Treatment of Stargardt DiseaseGlobeNewswire (press release)LEXINGTON, Mass. and LONDON, Nov. 08, 2017 (GLOBE NEWSWIRE) — Nightstar Therapeutics (NASDAQ:NITE), a clinical-stage gene therapy com… Continue reading
AccuRef Diagnostics Emerges as a New Division of Applied StemCell, Inc. With a Focus on Advancing Molecular …Business Wire (press release)MILPITAS, Calif.–(BUSINESS WIRE)–AccuRef Diagnostics (ARD) is announcing its formation as a new division under… Continue reading
Nivolumab-induced alterations revealedNature.comAbundant evidence exists that both tumour development, and responses to treatment are dynamic processes. Despite this solid evidence, knowledge of tumour evolution in response to immune-checkpoint inhibit… Continue reading
|
Even if This ALS Stem Cell Experiment Fails, It’ll Be Considered a Success
Daily Beast “I think it’s a very exciting potential to explore, to see if excitability of nerve cells is one of the reasons causing the disease and therefore this drug might dampen that,” she said. “We can ask questions of those [stem cell] lines and use them for … |
STAT |
Revolutionary new cancer therapies come with big risks. Drug makers must be prepared
STAT These new drugs, the first in the new family of CAR–T cell therapies 3, could revolutionize the treatment of blood cancers and make inroads into the treatment of solid tumors. They work by isolating immune cells 4 known as T cells from a patient’s … Cellectis gets FDA go-ahead to restart fatal CAR–T trialpharmaphorum |
Scottish Daily Record |
Five-year-old’s selfless stem cell donation ends teenage brother’s transfusion nightmare
Scottish Daily Record A teenager with a rare disorder has been told he should never need another blood transfusion – thanks to a stem cell donation from his sister. Sunny Farid, 18, had to spend one day in hospital every three weeks after being diagnosed with a condition … |
Villanovan |
Alumnus talks cancer immunotherapy
Villanovan On Nov. 3, the University community welcomed back Kevin J. Curran, M.D. (B.S., Biology, ’00) to speak about his research regarding cancer immunotherapy. Students, faculty and other members of the community gathered in the Driscoll Hall Auditorium to … Bowel cancer completely cured in miceGuardian (blog) |